Expression patterns of estrogen and androgen receptors in NSCLC patients according to the PD-L1 profile

BackgroundLung cancer is the leading cause of cancer-related death worldwide, with non-small cell lung cancer (NSCLC) being the most common type. Immunotherapy targeting programmed death ligand-1 (PD-L1) blockade has significantly improved survival, but differences in responses by sex have been repo...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Vianey Rodriguez-Lara, Gala Cortés-Ramírez, Itzel Amayrani Angeles-Torres, Jeronimo Rodriguez-Cid, Sally María Luisa Pedraza-Reyes, Maria Rosa Avila-Costa, José Luis Ordoñez-Librado, Marco Cerbón
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2025-06-01
Cyfres:	Frontiers in Immunology
Pynciau:	estrogen receptor androgen receptor NSCLC PD-L1 immunotherapy
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1602579/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!